BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2881340)

  • 1. Structural and functional studies of Gilles de la Tourette syndrome.
    Chase TN; Geoffrey V; Gillespie M; Burrows GH
    Rev Neurol (Paris); 1986; 142(11):851-5. PubMed ID: 2881340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological glutamatergic neurotransmission in Gilles de la Tourette syndrome.
    Kanaan AS; Gerasch S; García-García I; Lampe L; Pampel A; Anwander A; Near J; Möller HE; Müller-Vahl K
    Brain; 2017 Jan; 140(1):218-234. PubMed ID: 28007998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered structural connectivity of cortico-striato-pallido-thalamic networks in Gilles de la Tourette syndrome.
    Worbe Y; Marrakchi-Kacem L; Lecomte S; Valabregue R; Poupon F; Guevara P; Tucholka A; Mangin JF; Vidailhet M; Lehericy S; Hartmann A; Poupon C
    Brain; 2015 Feb; 138(Pt 2):472-82. PubMed ID: 25392196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study of clinical pictures and monoamine metabolism of Gilles de la Tourette syndrome].
    Takano K; Ishiguro T
    Seishin Shinkeigaku Zasshi; 1993; 95(1):1-29. PubMed ID: 7685527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Gilles de la Tourette syndrome: a principal component factor analytic study of a large pedigree.
    Robertson MM; Cavanna AE
    Psychiatr Genet; 2007 Jun; 17(3):143-52. PubMed ID: 17417057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropharmacology of tics.
    Fog R; Regeur L
    Rev Neurol (Paris); 1986; 142(11):856-9. PubMed ID: 2881341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural changes in the somatosensory system correlate with tic severity in Gilles de la Tourette syndrome.
    Thomalla G; Siebner HR; Jonas M; Bäumer T; Biermann-Ruben K; Hummel F; Gerloff C; Müller-Vahl K; Schnitzler A; Orth M; Münchau A
    Brain; 2009 Mar; 132(Pt 3):765-77. PubMed ID: 19136548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the pathophysiology and pathogenesis of Gilles de la Tourette syndrome.
    Friedhoff AJ
    Rev Neurol (Paris); 1986; 142(11):860-4. PubMed ID: 2950584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gilles de la Tourette syndrome in Papua New Guinea.
    Johnson FY
    P N G Med J; 1995 Jun; 38(2):127-32. PubMed ID: 9599974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gilles de la Tourette disease: review of the literature].
    Raffaele M; Silvestri R; De Domenico P; Di Perri R
    Riv Neurol; 1991; 61(4):145-9. PubMed ID: 1687713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deanol in Gilles de la Tourette Syndrome: a preliminary investigation.
    Pinta ER
    Dis Nerv Syst; 1977 Mar; 38(3):214-5. PubMed ID: 264808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Schizophrenic psychosis in a patient with Gilles de la Tourette syndrome].
    Becker T; Laux G; Sofic E; Riederer P; Beckmann H
    Nervenarzt; 1988 Oct; 59(10):616-20. PubMed ID: 2907104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroimaging techniques in the Gilles de la Tourette syndrome].
    Lampreave JL; Bittini A; Mateos F; Manzano S; Domínguez P
    Rev Neurol; 1996 Aug; 24(132):921-5. PubMed ID: 8755353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Compulsive disorder and Gilles de la Tourette syndrome. On the differential diagnosis of organic and psychogenic compulsive symptoms].
    Müller N; Putz A; Straube A; Kathmann N
    Nervenarzt; 1995 May; 66(5):372-8. PubMed ID: 7609819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100B protein, glia and Gilles de la Tourette syndrome.
    van Passel R; Schlooz WA; Lamers KJ; Lemmens WA; Rotteveel JJ
    Eur J Paediatr Neurol; 2001; 5(1):15-9. PubMed ID: 11277359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gilles de la Tourette syndrome and voluntary movement: a functional MRI study.
    Fattapposta F; Restuccia R; Colonnese C; Labruna L; Garreffa G; Bianco F
    Psychiatry Res; 2005 Apr; 138(3):269-72. PubMed ID: 15854795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Control of inner speech and Gilles de la Tourette's syndrome].
    Vercueil L
    Encephale; 2003; 29(5):460-2. PubMed ID: 14615696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence for a major gene effect of the dopamine D4 receptor gene in the susceptibility to Gilles de la Tourette syndrome in five Canadian families.
    Barr CL; Wigg KG; Zovko E; Sandor P; Tsui LC
    Am J Med Genet; 1996 May; 67(3):301-5. PubMed ID: 8725747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linkage study of the dopamine D5 receptor gene and Gilles de la Tourette syndrome.
    Barr CL; Wigg KG; Zovko E; Sandor P; Tsui LC
    Am J Med Genet; 1997 Feb; 74(1):58-61. PubMed ID: 9034008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome.
    Steeves TD; Fox SH
    Prog Brain Res; 2008; 172():495-513. PubMed ID: 18772048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.